Home
About us
Corporate Profile
Awards and Qualification
Social Responsibility
Diseases and solutions
Cardiovascular diseases
Uncontrolled and Resistant Hypertension
Peripheral Artery Disease
Vascular calcification (VC)
Product Center
Bioresorbable Scaffolds (BRS) and Ancillary Products
Renal Denervation (RDN)
Investor Relations
Corporate Information
Corporate Governance
Financial Reports
Performance Report
Prospectus
Announcements and Circulars
Investor Enquiries
News Center
News
Video
Contact us
Contact Us/Recruitment
简 / 繁 / EN
简体中文
繁體中文
English
Financial report
2024-04-26
2023 ANNUAL REPORT
2023-09-21
2023 INTERIM REPORT
2023-04-26
2022 ANNUAL REPORT
2022-09-19
2022 INTERIM REPORT
2022-04-22
2021 ANNUAL REPORT
